Acute Bacterial Parotitis due to Methicillin-resistant Staphylococcus aureus

Mohammed, Imran; Hofstetter, M.

doi:10.1097/01.smj.0000140830.66461.12

Cited by 8 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the frequent occurrence of patients with these risk factors, MRSA parotitis remains rare in the published literature, with only eight cases reported to our knowledge. The first case was described in 1990 and proved rapidly fatal (Rousseau, 1990), with seven cases being described subsequently (Manfredi et al, 1997;Cohen & Docktor, 1999;Chien et al, 2000;Molina et al, 2003;Mohammed & Hofstetter, 2004). Only three cases have described bacteraemia as a result of parotid gland infection with MRSA (Cohen & Docktor, 1999;Molina et al, 2003).…”

Section: Resultsmentioning

confidence: 99%

Two cases of parotid gland infection with bacteraemia due to meticillin-resistant Staphylococcus aureus

Enoch

Karas

Emery³

et al. 2006

Journal of Medical Microbiology

View full text Add to dashboard Cite

Parotid gland infection as a source of meticillin-resistant Staphylococcus aureus bacteraemia has been rarely reported. It is predominantly a disease of the elderly and is associated with significant mortality. Two cases are described here that presented over a 6 month history at a district general hospital. Many cases may be preventable with adequate hydration and good oral hygiene, combined with effective infection control.

show abstract

Section: Resultsmentioning

confidence: 99%

Two cases of parotid gland infection with bacteraemia due to meticillin-resistant Staphylococcus aureus

Enoch

Karas

Emery³

et al. 2006

Journal of Medical Microbiology

View full text Add to dashboard Cite

show abstract

“…It has been reported in institutionalized patients with cognitive deficits [5] and in one case of hemorrhagic stroke [6]. The reported ABP mortality ranges from 0 to > 50% [2,4].…”

Section: Discussionmentioning

confidence: 99%

Acute Bacterial Parotitis Following Acute Stroke

2008

View full text Add to dashboard Cite

Acute bacterial parotitis (ABP) is a relatively uncommon condition that tends to occur in debilitated older patients. We report a case of an older woman that presented with an acute intracerebral hemorrhage who developed ABP. This morbidity led to endotracheal intubation, mechanical ventilation, tracheostomy and gastrostomy, all of which were not initially needed. We discuss the proposed physiopathology and etiopathogenesis of ABP in adults.

show abstract

Treatment of Staphylococcus aureus Infections

David

Daum

2017

Current Topics in Microbiology and Immunology

102

View full text Add to dashboard Cite

Staphylococcus aureus, although generally identified as a commensal, is also a common cause of human bacterial infections, including of the skin and other soft tissues, bones, bloodstream, and respiratory tract. The history of S. aureus treatment is marked by the development of resistance to each new class of antistaphylococcal antimicrobial drugs, including the penicillins, sulfonamides, tetracyclines, glycopeptides, and others, complicating therapy. S. aureus isolates identified in the 1960s were sometimes resistant to methicillin, a ß-lactam antimicrobial active initially against a majority S. aureus strains. These MRSA isolates, resistant to nearly all ß-lactam antimicrobials, were first largely confined to the health care environment and the patients who attended it. However, in the mid-1990s, new strains, known as community-associated (CA-) MRSA strains, emerged. CA-MRSA organisms, compared with health care-associated (HA-) MRSA strain types, are more often susceptible to multiple classes of non ß-lactam antimicrobials. While infections caused by methicillin-susceptible S. aureus (MSSA) strains are usually treated with drugs in the ß-lactam class, such as cephalosporins, oxacillin or nafcillin, MRSA infections are treated with drugs in other antimicrobial classes. The glycopeptide drug vancomycin, and in some countries teicoplanin, is the most common drug used to treat severe MRSA infections. There are now other classes of antimicrobials available to treat staphylococcal infections, including several that have been approved after 2009. The antimicrobial management of invasive and noninvasive S. aureus infections in the ambulatory and in-patient settings is the topic of this review. Also discussed are common adverse effects of antistaphylococcal antimicrobial agents, advantages of one agent over another for specific clinical syndromes, and the use of adjunctive therapies such as surgery and intravenous immunoglobulin. We have detailed considerations in the therapy of noninvasive and invasive S. aureus infections. This is followed by sections on specific clinical infectious syndromes including skin and soft tissue infections, bacteremia, endocarditis and intravascular infections, pneumonia, osteomyelitis and vertebral discitis, epidural abscess, septic arthritis, pyomyositis, mastitis, necrotizing fasciitis, orbital infections, endophthalmitis, parotitis, staphylococcal toxinoses, urogenital infections, and central nervous system infections.

show abstract

Acute Bacterial Parotitis due to Methicillin-resistant Staphylococcus aureus

Cited by 8 publications

References 7 publications

Two cases of parotid gland infection with bacteraemia due to meticillin-resistant Staphylococcus aureus

Two cases of parotid gland infection with bacteraemia due to meticillin-resistant Staphylococcus aureus

Acute Bacterial Parotitis Following Acute Stroke

Treatment of Staphylococcus aureus Infections

Contact Info

Product

Resources

About